Urotensin II inhibits carotid sinus baroreflex in anesthetized male rats

Acta Pharmacologica Sinica

Volumn 28, Issue 2, 2007, Pages 216-220

  Wu, Yu Ming ^a   Xue, Hong Mei ^a   Xiao, Lin ^a   He, Rui Rong ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Baroreflex; BIM 23127; Carotid sinus; L NAME; Urotensin II; Vera pamil

Indexed keywords

BIM 23127; CALCIUM CHANNEL L TYPE; N(G) NITROARGININE METHYL ESTER; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; UROTENSIN II; VERAPAMIL;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CAROTID SINUS; CAROTID SINUS PRESSORECEPTOR REFLEX; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; NONHUMAN; RAT; VASCULAR SMOOTH MUSCLE;

ANESTHESIA; ANIMALS; BAROREFLEX; CAROTID SINUS; MALE; NG-NITROARGININE METHYL ESTER; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; UROTENSINS; VERAPAMIL;

EID: 33846497825     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00499.x     Document Type: Article

References (22)

1. Chartel N, Conlon JM, Collin F, Braun B, Waugh D, Vallarino M, et al. Urotensin II in the central system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization. J Comp Neurol 1996; 364: 324-39.
2. Conlon J M, Yano K, Waugh D, Hazon N. Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. J Exp Zool 1996; 275: 226-38.
3. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999; 401: 282-6.
4. Liu QY, Pong SS, Zeng ZZ. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 1999; 266: 174-8.
5. Mori M, Sugo T, Abe M, Shimomura Y, Kurihara M, Kitada C, et al. Urotensin II is the endogenous ligand of a G-protein-coupled receptor, SENR (GPR14). Biochem Biophys Res Commun 1999; 265: 123-9.
6. Totsune K, Taskahashi K, Arihara Z, Sone M, Stoh F, Ito S, et al. Role of urotension II in patients on dialysis. Lancet 2001; 358: 5-9.
7. Douglas SA, Sulpizio AC, Piercy V, Sarau HM, Ames RS, Aiyar NV, et al. Differential vasoconstrictor activity of human urotension-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol 2000; 131: 1262-74.
8. Maguire JJ, Kuc RE, Davenport AP. Orphan-receptor ligand human urotensin-II: receptor localization in human tissue and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 2000; 131: 441-6.
9. Stirrat A, Gallagher M, Douglas SA, Ohlstein EH, Berry C, Kirk A, et al. Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. Am J Physiol Heart Circ Physiol 2001; 280: 925-8.
10. Gibson A, Wallace P, Bern HA. Cardiovascular effects of urotensin II in anesthetized and pitched rats. Gen Comp Endocrinol 1986; 64: 435-9.
11. Gardiner SM, March JE, Kemp PA, Davenport AP, Bennet T. Depressor and regionally selective vasodilator effects of human and rat urotensin II in conscious rats. Br J Pharmacol 2001; 132: 1625-9.
12. Lin Y, Tsuchihashi T, Matsumura K, Abe I, Iida M. Central cardiovascular action of urotensin II in conscious rats. J Hypertens 2003; 21: 159-65.
13. Richards AM, Nicholls MG, Lainchbury JG, Fisher S, Yandle TG. Plasma urotensin II in heart failure. Lancet 2002; 360: 545-6.
14. Totsune K, Takahashi K, Arihara Z, Sone M, Ito S, Muramaki O. Increased plasma urotensin II levels in patients with diabetes mellitus. Clin Sci 2003; 104: 1-5.
15. Yi XL, Fan ZZ, He RR. An automatic system controlled by computer for carotid sinus perfusion. Chin J Appl Physiol 1993; 9: 156-9.
16. Wu YM, He RR. Bradykinin inhibits carotid sinus baroreflex in anesthetized rats. Acta Physiol Sin 1999; 51: 303-9.
17. Arndt JO. Baroreceptors: morphology and mechanics of receptor zones and sischarge properties of baroafferents. In: Zucker IH, Gilmore JP. editors. Reflex control of the circulation. Boston: CRC Press; 1991. p 103-8.
18. Tasaki K, Hori M, Ozaki H, Karaki H, Wakabayashi I. Mechanism of human urotension II-induced contraction in rat aorta. J Pharmacol Sci 2004; 94: 376-83.
19. Herold CL, Behm DJ, Buckley PT, Foley JJ, Wixted MM, Douglas SA. The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors. Br J Pharmacol 2003; 139: 203-7.
20. Gibson A. Complex effects of Gillichthys urotensin II on rat aortic strips. Br J Pharmacol 1987; 91: 205-12.
21. Li Z, Chapleau MW, Bates JN, Bielefeldt K, Lee HC, Abboud FM. Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons. Neuron 1998; 20: 1039-49.
22. Chapleau MW, Hajduczok G, Sha rma RV, Wachtel RE, Cunningham JT, Sullivan MJ, et al. Mechanisms of baroreceptor activation. Clin Exp Hypertens 1995; 17: 1-13.